Pfizer competitors

Pfizer Competitors include Urovant Sciences, Teva Pharmaceuticals, Johnson & Johnson, Novartis, Abbott and Roche.
Add company...
Pfizer
Pfizer
Pfizer is a biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
Urovant Sciences
Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
Teva Pharmaceuticals
Teva Pharmaceuticals
Teva Pharmaceutical operates as a pharmaceutical company.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Novartis
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
Abbott
Abbott
Abbott is a genomic disease management company that develops and markets clinical laboratory products.
Roche
Roche
Roche Holding is a diagnostics and pharmaceutical company.
Founding Date
Founding Date
1849
Founding Date
2016
Founding Date
1901
Founding Date
1886
Founding Date
1996
Founding Date
1991
Founding Date
1896
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Buenos Aires, AR
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
see more
Locations
HQ
Locations
Petah Tikva, IL HQ
Villa Adelina, AR
Macquarie Park, AU
Bakı, AZ
Minsk, BY
Mirabel, CA
see more
Locations
New Brunswick, US HQ
Buenos Aires, AR
Yerevan, AM
Broadway, AU
Dhaka, BD
Minsk, BY
Machelen, BE
see more
Locations
Basel, CH HQ
Núñez, AR
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
Praha 4, CZ
see more
Locations
Illinois City, US HQ
Sao Paulo, BR
Québec, CA
Shanghai, CN
Beijing, CN
Wiesbaden, DE
Tokyo, JP
see more
Locations
Basel, CH HQ
South San Francisco, US
Employees
Employees
90,2007% decrease
Employees
40
Employees
51,792
Employees
134,000
Employees
126,0004% increase
Employees
103,0004% increase
Employees
93,734
Valuation ($)
Valuation ($)
245.1 b
Valuation ($)
313.8 m
Valuation ($)
19.6 b
Valuation ($)
365.8 b
Valuation ($)
175.5 b
Valuation ($)
132.2 b
Valuation ($)
N/A
Twitter followers
Twitter followers
13.3 k
Twitter followers
N/A
Twitter followers
2.8 k
Twitter followers
90.5 k
Twitter followers
234.4 k
Twitter followers
61.1 k
Twitter followers
177.2 k

Financial

Revenue (est.)
Revenue (est.)
$52.5b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$22.4b (FY, 2017)
Revenue (est.)
$76.5b (FY, 2017)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
$27.4b (FY, 2017)
Revenue (est.)
CHF48.1b (FY, 2015)
Cost of goods
Cost of goods
$11.2b (FY, 2017)
Cost of goods
N/A
Cost of goods
$11.6b (FY, 2017)
Cost of goods
$25.4b (FY, 2017)
Cost of goods
$17.2b (FY, 2017)
Cost of goods
$12.3b (FY, 2017)
Cost of goods
CHF15.5b (FY, 2015)
Gross profit
Gross profit
$41.3b (FY, 2017)
Gross profit
N/A
Gross profit
$10.8b (FY, 2017)
Gross profit
$51.1b (FY, 2017)
Gross profit
$31.9b (FY, 2017)
Gross profit
$15.1b (FY, 2017)
Gross profit
CHF32.7b (FY, 2015)
Net income
Net income
$21.3b (FY, 2017)
Net income
N/A
Net income
($16.4b) (FY, 2017)
Net income
$1.3b (FY, 2017)
Net income
$7.7b (FY, 2017)
Net income
$477m (FY, 2017)
Net income
CHF9.1b (FY, 2015)

Operating

Countries
Countries
125 (FY, 2017)
Countries
N/A
Countries
N/A
Countries
60 (FY, 2017)
Countries
N/A
Countries
N/A
Countries
N/A
Discovery Projects
Discovery Projects
87 (FY, 2017)
Discovery Projects
N/A
Discovery Projects
N/A
Discovery Projects
150 (FY, 2015)
Discovery Projects
N/A
Discovery Projects
N/A
Discovery Projects
N/A
Drugs Approved by FDA
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (FY, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (Y, 2015)
Major Approvals (US, EU, JP)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
16 (Y, 2016)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
12 (Y, 2016)
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
88 (FY, 2017)
Manufacturing Facilities
125 (FY, 2017)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Phase III Trials Products
Phase III Trials Products
29 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
37 (Jan, 2019)
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 358m
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
$ 6.8m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Urovant Sciences
HQ
Employees
40

Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.

View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
51,792

Teva Pharmaceutical operates as a pharmaceutical company.

View company
Johnson & Johnson
HQ
New Brunswick, US
Employees
134,000

Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.

View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company